| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | General Counsel | Common Stock | 161,493 | $784,856 | $4.86 | 05 Feb 2024 | Direct |
| OCULAR THERAPEUTIX, INC | General Counsel | Stock Option (Right to Buy) | 175,000 | 03 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | 03 Feb 2024 | 3 | +$29,301 | 4 | General Counsel | 06 Feb 2024, 18:35 |
| OCUL | OCULAR THERAPEUTIX, INC | 31 Jan 2024 | 1 | -$33,813 | 4 | General Counsel | 02 Feb 2024, 19:01 |
| OCUL | OCULAR THERAPEUTIX, INC | 06 Feb 2023 | 1 | -$26,207 | 4 | General Counsel | 08 Feb 2023, 18:31 |
| OCUL | OCULAR THERAPEUTIX, INC | 30 Jan 2023 | 2 | $0 | 4 | General Counsel | 01 Feb 2023, 18:35 |
| OCUL | OCULAR THERAPEUTIX, INC | 03 Feb 2022 | 2 | $0 | 4 | General Counsel | 07 Feb 2022, 18:33 |